Evidence map›Paper›PMID 32778653›Full record

ArticleNature communications2020

Antibody-secreting cell destiny emerges during the initial stages of B-cell activation.

Christopher D Scharer, Dillon G Patterson, Tian Mi, Madeline J Price, Sakeenah L Hicks, Jeremy M Boss

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. iScience · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Regulation of BCR-mediated CaScience immunology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christopher D Scharer *Department of Microbiology and Immunology and the Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID http://orcid.org/0000-0001-7716-8504
Dillon G Patterson *Department of Microbiology and Immunology and the Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID http://orcid.org/0000-0001-6053-5216
Tian MiDepartment of Microbiology and Immunology and the Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID http://orcid.org/0000-0002-6446-1995
Madeline J PriceDepartment of Microbiology and Immunology and the Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID http://orcid.org/0000-0002-4947-7382
Sakeenah L HicksDepartment of Microbiology and Immunology and the Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Jeremy M BossDepartment of Microbiology and Immunology and the Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA. jmboss@emory.edu.ORCID http://orcid.org/0000-0002-2432-1840
Emory University · USEmory Healthcare · US

Funding

Regulation of Pathogenic Plasma Cells in Human SLEP01AI125180 · NIAID · EMORY UNIVERSITY · PI Ignacio E. Sanz · 2016 to 2026
$28.2M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
Epigenetic Regulation of Plasma Cells DifferentiationR01AI123733 · NIAID · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 2016 to 2020
$1.9M
Epigenetic Regulation of Memory B Cell Differentiation and ReactivationF31AI138391 · NIAID · EMORY UNIVERSITY · PI PRICE, MADELINE JOAN · 2018 to 2019
$73k
NIAID NIH HHS F31 AI138391NIAID NIH HHS R01 AI123733NIGMS NIH HHS T32 GM008490
6 · The paper itself

Abstract

Upon stimulation, B cells assume heterogeneous cell fates, with only a fraction differentiating into antibody-secreting cells (ASC). Here we investigate B cell fate programming and heterogeneity during ASC differentiation using T cell-independent models. We find that maximal ASC induction requires at least eight cell divisions in vivo, with BLIMP-1 being required for differentiation at division eight. Single cell RNA-sequencing of activated B cells and construction of differentiation trajectories reveal an early cell fate bifurcation. The ASC-destined branch requires induction of IRF4, MYC-target genes, and oxidative phosphorylation, with the loss of CD62L expression serving as a potential early marker of ASC fate commitment. Meanwhile, the non-ASC branch expresses an inflammatory signature, and maintains B cell fate programming. Finally, ASC can be further subseted based on their differential responses to ER-stress, indicating multiple development branch points. Our data thus define the cell division kinetics of B cell differentiation in vivo, and identify the molecular trajectories of B cell fate and ASC formation.

Indexed as

AnimalsAntibody-Producing CellsAntigens, CD19B-LymphocytesCell DifferentiationImmunityInterferon Regulatory Factor-4Interferon Regulatory FactorsL-SelectinLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutPositive Regulatory Domain I-Binding Factor 1TranscriptomeAntigens, CD19CD19 antigen, mouseInterferon Regulatory Factor-4Interferon Regulatory FactorsL-SelectinPositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouse

Identifiers

PMID32778653
PMCPMC7417592
OpenAlexW3048004273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.